Search research articles
Contact Us
Filters
Showing results (471-480 of 692) with videos related to
Page
of 70
Sort By:
Psychological Medicine
|
October 22, 2014
Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial
H K Ising, F Smit, W Veling, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
J H R J Degens, K J C Sanders, E E C de Jong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2019
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients
Pauline L de Goeje, Myrthe Poncin, Koen Bezemer, et al.
Frontiers in Oncology
|
February 7, 2024
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report
Myriam Mirza, Aseem Shrivastava, Cecile Matthews, et al.
Arthritis Research & Therapy
|
April 16, 2011
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
Maria J Overbeek, Anco Boonstra, Alexandre E Voskuyl, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib
Vivian E M van den Boogaart, Quido G de Lussanet, Ruud M A Houben, et al.
Molecular Oncology
|
November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer
Franziska Böttger, Teodora Radonic, Idris Bahce, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)
M E R O'Brien, T Splinter, E F Smit, et al.
Nature Medicine
|
August 10, 2021
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure
Joris van de Haar, Louisa R Hoes, Paul Roepman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy
Gijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Page
of 70
Search research articles
Search
Showing results (471-480 of 692) with videos related to
Sort By:
Page
of 70
Psychological Medicine
|
October 22, 2014
Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial
H K Ising, F Smit, W Veling, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 16, 2019
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
J H R J Degens, K J C Sanders, E E C de Jong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2019
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients
Pauline L de Goeje, Myrthe Poncin, Koen Bezemer, et al.
Frontiers in Oncology
|
February 7, 2024
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report
Myriam Mirza, Aseem Shrivastava, Cecile Matthews, et al.
Arthritis Research & Therapy
|
April 16, 2011
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
Maria J Overbeek, Anco Boonstra, Alexandre E Voskuyl, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib
Vivian E M van den Boogaart, Quido G de Lussanet, Ruud M A Houben, et al.
Molecular Oncology
|
November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer
Franziska Böttger, Teodora Radonic, Idris Bahce, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)
M E R O'Brien, T Splinter, E F Smit, et al.
Nature Medicine
|
August 10, 2021
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure
Joris van de Haar, Louisa R Hoes, Paul Roepman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy
Gijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Page
of 70